Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The exocyst is an insulin-sensitive regulator of amyloid precursor protein trafficking and amyloid-beta generation in neurons.

bioRxiv : the preprint server for biology·2026
Same author

PaedIatric caNcelation ratEs And PerioPerative clinicaL Evaluation (PINEAPPLE): A UK Prospective Multi-Center Observational Cohort Study.

Paediatric anaesthesia·2026
Same author

Importance of targeting post-prandial hyperglycaemia to achieve HbA1c goals in insulin glargine-treated subphenotypes of type 2 diabetes.

Diabetes, obesity & metabolism·2025
Same author

A multivariate analysis to identify the relationship between sociodemographic differences and examination performance in UK postgraduate medical examinations.

Journal of the Royal Society of Medicine·2025
Same author

A multivariate analysis examining the relationship between sociodemographic differences and UK graduates' performance on postgraduate medical exams.

Medical teacher·2025
Same author

Differential attainment in UK postgraduate medical examinations: examining the relationship between sociodemographic differences and examination performance.

BMC medicine·2025
Same journal

Trends and disparities in thyroid cancer related mortality from 1999 to 2023: about CDC WONDER database analysis.

BMC endocrine disorders·2026
Same journal

Real-world effectiveness of quadruple oral hypoglycemic therapy in type 2 diabetes patients refusing insulin therapy.

BMC endocrine disorders·2026
Same journal

Association between HbA1c and red cell distribution width-standard deviation in newly diagnosed, treatment-naïve type 2 diabetes mellitus: a retrospective cross-sectional study.

BMC endocrine disorders·2026
Same journal

Serum anti-Müllerian hormone levels in women following bariatric surgery: insights from a systematic review and meta-analysis.

BMC endocrine disorders·2026
Same journal

Prevalence of food addiction and its association with ghrelin and metabolic parameters in patients with type 1 diabetes mellitus: a cross-sectional study.

BMC endocrine disorders·2026
Same journal

Machine learning-assisted prediction of obstructive sleep apnea in patients with metabolic dysfunction-associated steatotic liver disease: a multicenter study with external validation.

BMC endocrine disorders·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2026

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
06:13

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Published on: December 1, 2023

The Edinburgh Type 2 Diabetes Study: study protocol.

Jackie F Price1, Rebecca M Reynolds, Rory J Mitchell

  • 1Division of Community Health Sciences and Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK. Jackie.Price@ed.ac.uk

BMC Endocrine Disorders
|December 17, 2008
PubMed
Summary
This summary is machine-generated.

The Edinburgh Type 2 Diabetes Study investigates risk factors for diabetes complications like cognitive impairment and liver disease. This research aims to identify modifiable factors for better prevention and treatment strategies.

Related Experiment Videos

Last Updated: Jun 27, 2026

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
06:13

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Published on: December 1, 2023

Area of Science:

  • Endocrinology and Metabolism
  • Epidemiology
  • Gerontology

Background:

  • Type 2 diabetes complications, including cognitive impairment and non-alcoholic fatty liver disease, have poorly understood risk factors.
  • The Edinburgh Type 2 Diabetes Study (ET2DS) was established to investigate these risks.
  • The study also examines mechanisms of micro- and macrovascular disease in type 2 diabetes.

Purpose of the Study:

  • To identify potential risk factors for cognitive impairment and non-alcoholic fatty liver disease in type 2 diabetes.
  • To investigate the mechanisms behind micro- and macrovascular complications.
  • To gather data for developing preventive and therapeutic interventions.

Main Methods:

  • Prospective cohort study design.
  • Recruited 1066 participants aged 60-75 with type 2 diabetes (2006-2007).
  • Baseline and one-year follow-up assessments included cognitive, physical, vascular, metabolic, and liver function tests.

Main Results:

  • This paper reports on the recruitment and baseline/one-year examination methods.
  • Detailed epidemiological and biomarker data were collected.
  • Long-term follow-up assessments are scheduled.

Conclusions:

  • The study will yield valuable data for identifying modifiable risk factors.
  • Findings are expected to aid in developing targeted interventions for diabetes-related complications.
  • The research aims to improve prevention and treatment of cognitive, liver, and vascular issues in type 2 diabetes.